Replies to post #26150 on Delcath Systems Inc (DCTH)

[Rapture2020]

Hasn’t wiped anyone out.

Let’s assume after all said and done the OS is 30M. That’s STILL a TINY float.

$10.5M million interest free (cash on hand to finish Phase III trials); Interim safety analysis report due at any time; profits are increasing each quarter; any other news (e.g update on FDA orphan drugs) is a wildcard.

All of this for $.07 a share?

How could one ask for anything more?!?!

Kings can be crowned here.